Chas, I agree with you that they tilted the study in their favor by having V being taken incorrectly, and that can be easily seen when comparing the blood levels with the other studies such as Anchor, Marine, etc. Since they were simply studying blood levels, not blinding is not consequential and I grew up and studied science in Canada so not sure why you think trials in Canada indicates anything.
I just searched UpToDate for this recommendation you mention (I have a subscription), and as far as I can see there is no such thing there. Where did you hear this?
I searched for Vascepa and for Icosapent, and I do not see anything mentioning it in context of mineral oil. The only thing I could find was this:
"Another commercial preparation, Vascepa, is more than 95 percent icosapent ethyl, the ethyl ester of eicosapentaenoic acid [107]. In a small trial of patients with very high fasting triglyceride levels, icosapent-ethyl (4 g/day) reduced triglyceride levels by up to 45 percent but did not significantly affect LDL cholesterol levels [108]."
Also Kastelein is not listed as an author of any article.
Not saying it isn't there but if it is it is very difficult to find. But it is more likely some idiot on StockTwits is lying again, knowing that people without a subscription wouldn't be able to check (sigh)